Fagron

Fagron publishes annual report 2023

14 Mar 2024 13:30:00 By Nasdaq GlobeNewswire

Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023

15 Feb 2024 01:00:00 By Nasdaq GlobeNewswire

Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold

08 Jan 2024 02:00:00 By Nasdaq GlobeNewswire

Disclosure of notification received from BNP Paribas Asset Management SA

11 Dec 2023 12:00:00 By Nasdaq GlobeNewswire

Disclosure of notification received from BNP Paribas Asset Management SA

09 Nov 2023 12:00:00 By Nasdaq GlobeNewswire

Continued strong third quarter performance with 11% topline growth to €191 million

12 Oct 2023 01:00:00 By Nasdaq GlobeNewswire

Fagron completes share buy-back program

19 Sep 2023 12:08:40 By Nasdaq GlobeNewswire

Progress share buy-back program Fagron

15 Sep 2023 12:11:21 By Nasdaq GlobeNewswire

Progress share buy-back program Fagron

08 Sep 2023 12:03:24 By Nasdaq GlobeNewswire

Progress share buy-back program Fagron

01 Sep 2023 12:10:17 By Nasdaq GlobeNewswire

Progress share buy-back program Fagron

25 Aug 2023 12:09:18 By Nasdaq GlobeNewswire

Progress share buy-back program Fagron

18 Aug 2023 12:05:47 By Nasdaq GlobeNewswire

Fagron delivers strong performance with 13% topline growth and 14% increase in REBITDA for first half of 2023

03 Aug 2023 01:00:00 By Nasdaq GlobeNewswire

Fagron shareholders approve majority voting items

08 May 2023 13:00:00 By Nasdaq GlobeNewswire

Fagron increases share capital through exercise subscription rights

03 May 2023 02:00:00 By Nasdaq GlobeNewswire

Strong first quarter performance with 16% topline growth to €181 million

13 Apr 2023 01:00:00 By Nasdaq GlobeNewswire

Fagron publishes agenda for annual shareholders meeting

07 Apr 2023 02:00:00 By Nasdaq GlobeNewswire

Disclosure of notification received from FMR LLC

20 Mar 2023 13:30:00 By Nasdaq GlobeNewswire

Fagron publishes annual report 2022

20 Mar 2023 03:00:00 By Nasdaq GlobeNewswire

Fagron reports 19% topline growth, 11% increase in REBITDA and free cash flow of €91 million for 2022

09 Feb 2023 01:00:00 By Nasdaq GlobeNewswire